Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.

IF 4.5 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2024-11-15 DOI:10.1038/s41409-024-02438-5

Lan-Ping Xu, Pei-Hua Lu, De-Pei Wu, He Huang, Er-Lie Jiang, Dai-Hong Liu, Wei-Jie Cao, Xi Zhang, Yue-Wen Fu, Nai-Nong Li, Xin-Chuan Chen, Xiao-Yu Zhu, Qi-Fa Liu, Ling-Hui Xia, Yi-Cheng Zhang, Ya-Jing Xu, Fu-Chun Li, Jiong Hu, Si-Xi Liu, Rong-Rong Liu, Xiao-Di Ma, Xiao-Wen Tang, Yi Luo, Xiao-Hui Zhang, Xiao-Jun Huang

引用次数: 0

查看原文本刊更多论文

更正：2022-2023年中国造血干细胞移植活动。干细胞来源中外周血的比例持续增长：中国造血干细胞移植登记组的报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.